Nymox Drops Delaware Matter Against Ascella: What Does This Mean for Shareholders and the World? In a recent development, Irvine, California-based biotech company Nymox (NYMX) announced on March 11, 2025, that it had dismissed the Delaware matter pending against Ascella Biotech, a subsidiary of Nymox. The dismissal came on March 7, 2025, after careful consideration…
Breaking News: Class Action Lawsuit Filed Against Digimarc Corporation New York, NY, March 11, 2025 Pomerantz LLP, a leading national securities law firm, announced today that a class action lawsuit has been filed against Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC). The complaint, filed in the United States District Court for the District of…
Understanding the TELUS International Lawsuit: What It Means for Investors and the World Investing in the stock market comes with inherent risks, and sometimes, even the most carefully chosen investments can result in losses. One such investment that has recently been the subject of a securities class action lawsuit is TELUS International (Cda) Inc. (TIXT)….
Gilead Sciences Unveils New Data on Lenacapavir for HIV Prevention Foster City, CA – In a significant stride towards advancing HIV prevention, Gilead Sciences, Inc. recently shared the initial findings from their Phase 1 study on two new, once-yearly formulations of lenacapavir at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). Lenacapavir is an…
Top Stocks to Watch: Insights from the Investment Committee The Investment Committee, a distinguished group of financial experts, has recently announced their top stocks to watch for the second half of the year. These stocks represent promising opportunities for investors seeking growth and stability in their portfolios. Let’s delve deeper into each pick. Microsoft Corporation…
ANTHERM-UC Study: Protagonist and Janssen’s Icotinib in Ulcerative Colitis – Primary Endpoint Achieved In a recent development in the field of gastrointestinal research, the phase IIb ANTHEM-UC study evaluating Protagonist Therapeutics’ PTG-300 (icotinib) and Janssen Pharmaceuticals’ infliximab (Remicade) combination therapy for treating ulcerative colitis (UC) has announced the achievement of its primary endpoint. This news…
Anticipated Gemini Embrace of Cardano: A New Era for ADA Participants There has been an escalating buzz within the Cardano community and cryptocurrency market as a whole regarding the potential listing of ADA, the native cryptocurrency of the Cardano blockchain, on the renowned cryptocurrency exchange, Gemini. Pro-Cardano industry participants have set their sights on March…
Ferguson Enterprises Inc. (NYSE: FERG ) Q2 2025 Results Conference Call On March 11, 2025, Ferguson Enterprises Inc., a leading global distributor of plumbing, heating, cooling, and mechanical products, held its Q2 2025 earnings conference call. The call was led by Brian Lantz, Vice President of Investor Relations, Kevin Murphy, President and CEO, and Bill…
